INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble
Go back to INmune Bio's Alzheimer's drug falls short of mid-stage study goal, shares tumble| (NASDAQ: INMB) | Delayed: 1.42 -0.01 (0.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $ | |||
| Open | $1.39 | 52 Week Low | $ | |||
| Day High | $1.50 | P/E | N/A | |||
| Day Low | $1.39 | EPS | $ | |||
| Volume | 432,229 | |||||
